CLIC3 Antibodies

Santa Cruz Biotechnology features a diverse variety of CLIC3 monoclonal antibodies for research focused on understanding CLIC3 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CLIC3, or Chloride Intracellular Channel 3, belongs to the CLIC family of proteins and facilitates cellular chloride ion transport while regulating cell volume. CLIC3 participates in essential physiological processes, including cell signaling, apoptosis, and cellular differentiation. Research has shown CLIC3's significance in cancer development and progression, highlighting its potential as a therapeutic target. Investigating CLIC3 expression and activity patterns can reveal new insights into disease mechanisms and treatment strategies. Understanding CLIC3's molecular interactions and regulatory pathways may lead to breakthrough therapeutic approaches. Ongoing studies continue to uncover novel functions and regulatory mechanisms of CLIC3 in both normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CLIC3's role in human health and disease.